For autoimmune diseases PCAF alleviates collagen-induced arthritis by coordinately inhibiting NF-κB and H3K9ac (71) with similar polarization imbalances observed in systemic lupus erythematosus and immune thrombocytopenia (72). The gene discussed is NFKB1; the disease is systemic lupus erythematosus.